frequency of hypoglycemic episodes, glucose variability and lipid profiles of inpatients with poorly regulated type 1 diabetes mellitus (T1DM) after evening versus morning glargine application.
Methods: Eighteen patients with poorly regulated T1DM, glycated hemoglobin (Hba1c) levels C7% and frequent nocturnal and/or morning hypoglycemic episodes were included in this study. There was a 12-week screening phase where patients continued their usual insulin regimen and were encouraged to achieve optimal glycemic control; however, all patients maintained HbA1c values C7% and continued to have frequent nocturnal and/or morning hypoglycemic events and were therefore transitioned to morning application of insulin glargine for 12 weeks. The primary outcome was to investigate changes in HbA1c values 12 weeks after the transition. The secondary outcome was to evaluate the effect of transition on glucose variability, incidence of hypoglycemic episodes, insulin doses, lipid profile and weight. Data were analyzed using paired Student's t test and Pearson correlation. Results: After the transition, there was no significant change in total daily dose of basal insulin (p 0.114) and the average body weight remained unchanged, while significant reduction of HbA1c was present (8.02 ± 0.5 vs. Compliance with Ethics Guidelines 
RESULTS
A total number of 18 patients with T1DM were analyzed.
Patients' average age was 33.1 ± 9.1 years and the average duration of diabetes was 19.7 ± 12.0 years on intensified therapy with insulin analogs. HbA1c with morning and bedtime insulin glargine dosages as the present study [2, 3] ; however, those studies showed no significant difference in the frequency or duration of hypoglycemia during the day or the night irrespective of the timing of glargine injection [3] . In the present study, a significant reduction of HbA1c was registered at 12 weeks after initial transition, without changes in insulin doses and with lower rates of hypoglycemic episodes (especially in the morning). Decrease in pre-lunch and pre-dinner BG values and an increase in fasting glycaemia were also observed. This suggests that an improvement of overall glycemic control was achieved due to [7] . Obviously, increases in bedtime doses of hypoglycemic agents may correct early morning hyperglycemia but may also be associated with undesirable nocturnal and early morning hypoglycemia as well as reactive hyperglycemia during the daytime leading to overall poor glycemic control and acute glucose fluctuations.
The present study has several limitations. The number of subjects was small and the treatment period short. It is also an observational study and thus potentially biased since study effect cannot be excluded although there was a 3-month run in period with strict self control. A large-scale, long-term randomized clinical study is required for confirmation of the present results. 
